Home > Journals > La Rivista Italiana della Medicina di Laboratorio > Past Issues > Articles online first > La Rivista Italiana della Medicina di Laboratorio 2020 May 08

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

 

La Rivista Italiana della Medicina di Laboratorio 2020 May 08

DOI: 10.23736/S1825-859X.20.00059-6

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: Italian

How to differentiate a good from a bad (medical) decision?

Joseph WATINE

Laboratoire de Biologie Médicale, Centre Hospitalier, Villefranche-de-Rouergue Cedex, France


PDF


The Monitor discusses the concepts of benefits-to-harms and benefits-to-risks ratios in Medicine and the uncertainty for a “true” definition of them, on the basis of the concept of evidence (with its biases and limits) and of the judgments about the pieces of evidence (depending on knowledge, values, beliefs of both physicians and patients) offered by Evidence-based Medicine. Moreover, for a proposal of a general rule for defining good or bad a medical decision, understanding both the individual decisional autonomy and the human community equity is needed.


KEY WORDS: Benefits-to-harms ratio; Evidence-based medicine; Patient autonomy; Equity

top of page